Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.1 USD | -0.86% | -3.72% | +338.96% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Janux Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Janux Therapeutics, Inc.
Wedbush | |
JonesTrading Institutional Services | |
BTIG | |
Cantor Fitzgerald | |
HC Wainwright | |
William Blair & Co. | |
Cowen | |
Evercore ISI | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- JANX Stock
- Consensus Janux Therapeutics, Inc.